טוען...
[60]Fullerene for Medicinal Purposes, A Purity Criterion towards Regulatory Considerations
Since the early nineties countless publications have reported promising medicinal applications for [60]fullerene (C<sub>60</sub>) related to its unparalleled affinity towards free radicals. Yet, until now no officially approved C<sub>60</sub>-based drug has reached the market...
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI AG
2019-08-01
|
| סדרה: | Materials |
| נושאים: | |
| גישה מקוונת: | https://www.mdpi.com/1996-1944/12/16/2571 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|